Advertisement
Advertisement
TOPIC

Biomedicine: Science

Related Topics:
Biomedicine: Science
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
Beijing has stepped up R&D spending in recent years as it seeks to support innovation across strategic industries. Photo: Shutterstock
China technology

China’s R&D spending tops OECD average for first time. What comes next?

Beijing plans to double down on basic research, cutting-edge technologies and scientific talent as it strives to achieve tech self-sufficiency.

13
Biomedicine: Industry Trends

How Chinese biotech is graduating from licensing deals to broader partnerships

Science

Biomedicine | China’s CAR-T cell therapy cancer breakthrough shows progress

Biomedicine: Industry Trends

Can targeted sound waves transform treatment for pancreatic and brain cancers?

A leading advocate says global trials in pancreatic and brain cancers may yield results within 3 years, with Alzheimer’s another application.

Focused ultrasound is being studied as a non-invasive way to target brain tumours including glioblastoma, an aggressive form of the disease. Photo: Shutterstock
China technology

Video | New device helps stroke survivors walk more naturally

Stroke survivors can face numerous complications, including brain injury, memory loss, speech impairments and motor issues.

Greater Bay Area

Hong Kong targets biomedicine powerhouse status in debut 5-year plan

Tied to the national strategy, the city’s first five-year blueprint doubles down on Greater Bay Area medical tech and healthcare cooperation.

Advertisement
Advertisement
Advertisement
Science

US, China trials suggest a single nanodrug shot might stop bad cholesterol forever

Separate trials using CRISPR and base editing to silence lipid genes show drastic drops in LDL-C without daily medication.

videocam
Two breakthrough clinical trials suggest that patients with high cholesterol may one day benefit from a one-and-done injection to keep bad cholesterol under control. Photo: Shutterstock Images
IPO

More Chinese developers of brain-computer interfaces move towards IPOs

Arfysica and Neuracle aim for Star Market listings amid what a Morgan Stanley analyst calls the ‘early stage of a multi-year IPO upcycle’.

videocam
Banking & finance

US surgical robotics firm targets Hong Kong listing to tap mainland China market

Noah Medical expects to file application as early as next year, joining surge of tech listings tapping city’s international fundraising pool.

videocam
Artificial intelligence

Biomedicine | China thinks big on brain-computer interfaces

Launch of commercial BCI implantation, ahead of US, offers hope to millions with brain or spinal injuries as plans are made for the technology’s wider use.

China thinks big on brain-computer interfaces after world-first surgery
Science

Chinese stem cell therapy restores heart function in 90% of trial patients

Study finds patients injected with iPSC-derived heart muscle cells outperform control group on cardiac function tests after bypass surgery.

videocam
12
Patients with severe heart failure may experience shortness of breath after walking just a few steps, the inability to lie flat and sleep at night, and frequent hospital visits. Photo: Shutterstock
Science

Chinese ‘yeast factory’ boosts cancer drug production by 1,000 times

Turning point comes from cross-disciplinary collaboration, including across plant biochemistry, synthetic biology and protein engineering.

videocam
China’s private sector

China’s drug firms set to compete on the world stage, analysts say

Amid systemic efficiency and a wave of innovation, the country’s biotech sector is expanding at a pace that has caught the market off guard.

4
China’s private sector

Sugar for the pill: US$8b fund boosts Hong Kong’s biotech hub ambitions

Hong Kong Investment Corporation is stepping up its efforts to position itself amid Beijing’s challenge to US pharmaceutical dominance.

Clara Chan Ka-chai, CEO of Hong Kong Investment Corporation (HKIC) Photo: Enoch Yiu
Banking & finance

As weight-loss drug orders surge, global funds pile into China’s WuXi AppTec

Pharmaceutical contractor’s GLP-1 programmes and surging stock gains have made it a magnet for global investors.

WuXi AppTec was expected to release its half-year earnings results on August 3. Photo: Handout
Banking & finance

Healthcare IPO wave: US biotech firm picks Hong Kong over Nasdaq for listing

Axiom Biosciences founder says Hong Kong investors show greater maturity than Nasdaq in handling biotech companies.

China’s private sector

China’s biotech boom: RAS-targeted drugs challenge US dominance

The rapid development of China’s RAS-targeted cancer drugs could reshape global oncology and unlock the country’s undervalued biotech firms.

Advertisement
Advertisement
Advertisement
China’s private sector

China AI drug-design deals swell as US scrutiny mounts

Global pharmaceutical firms are tapping into Chinese artificial intelligence assets before patents expire on blockbuster drugs, advancing AI-driven biotech.

videocam
Industry insiders say AI-powered drug-design tools have the potential to shorten development timelines from years to as few as 18 months. Photo: Shutterstock
Medicine

China closing in but US leads in biotech quality and commercial reach: survey

The Cure survey said China leads ⁠in clinical development and supply chain, and rated US funding cuts a bigger threat than China competition.

videocam
China’s private sector

Which company could become the Chinese Pfizer? Here are analysts’ top picks

A boom in outlicensing agreements leads to a debate over which Chinese firms may be first to break into overseas markets with own brands.

China’s private sector

With AI able to predict disease, can we treat ageing like a ‘bug’ in the system?

AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks.

Illustration: Lau Ka-kuen
Science

Biomedicine | China steps up Alzheimer’s, Parkinson’s drug push, looks to TCM

With the most cases of the two leading neurodegenerative diseases, and affected population rising as country ages, China needs to find new treatments.

China steps up Alzheimer’s, Parkinson’s drug push, looks to TCM
Biomedicine: Companies

China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials

The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.

videocam
Science

Chinese team uses supercomputer to cut drug screening time from years to seconds

AI platform that can screen vast library of chemical compounds opens up new frontiers in fight against cancer and infectious diseases.

videocam
China’s private sector

Insilico, US partner to build AI models predicting disease decades ahead

Tie-up combines Hong Kong-listed Insilico Medicine’s algorithms with Human Longevity’s genomic data to advance personalised health research.

The global longevity market, fuelled by an ageing population and rising consumption demand, is currently valued at US$5.3 trillion, according to a UBS report. Photo: Shutterstock
Science

Chinese scientists grow heart’s ‘master conductor’ that could replace pacemaker

Shanghai researchers engineer biological pacemaker that could offer a new way to control abnormal heart rhythms.

videocam
The findings of Chinese scientists may offer possibilities for future biological pacemaker strategies, according to their paper. Image: Shutterstock
US-China relations

As I see it | US’ scientific self-harm will only help China

While Washington slashes funding for the sciences, Beijing is clinching its lead in everything from patent applications to publications.

videocam
16
Biomedicine: Companies

China biotech deals hit record as innovative drugs draw global interest

Deals reach US$60 billion in first quarter after analysts say Chinese biotech firms have shown substantial technological advancements.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement